2022
Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation
Stahlberg E, Abdel-Rahman M, Aguilar B, Asadpoure A, Beckman R, Borkon L, Bryan J, Cebulla C, Chang Y, Chatterjee A, Deng J, Dolatshahi S, Gevaert O, Greenspan E, Hao W, Hernandez-Boussard T, Jackson P, Kuijjer M, Lee A, Macklin P, Madhavan S, McCoy M, Mirzaei N, Razzaghi T, Rocha H, Shahriyari L, Shmulevich I, Stover D, Sun Y, Syeda-Mahmood T, Wang J, Wang Q, Zervantonakis I. Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation. Frontiers In Digital Health 2022, 4: 1007784. PMID: 36274654, PMCID: PMC9586248, DOI: 10.3389/fdgth.2022.1007784.Peer-Reviewed Original ResearchMonitoring treatment responsePatient digital twinsUS National Cancer InstituteNational Cancer InstituteTreatment responsePlanning treatmentEarly progressionCancer preventionDigital twin approachIndividual patientsPersonalized treatmentPilot projectCancer InstituteCancer typesCancerDigital twinDeep phenotypingCancer researchPatients
2020
Population-Based Screening for Endometrial Cancer: Human vs. Machine Intelligence
Hart GR, Yan V, Huang GS, Liang Y, Nartowt BJ, Muhammad W, Deng J. Population-Based Screening for Endometrial Cancer: Human vs. Machine Intelligence. Frontiers In Artificial Intelligence 2020, 3: 539879. PMID: 33733200, PMCID: PMC7861326, DOI: 10.3389/frai.2020.539879.Peer-Reviewed Original ResearchAverage-risk womenEndometrial cancerRisk womenOvarian Cancer Screening TrialEndometrial cancer riskCancer Screening TrialPrimary care physiciansPopulation-based screeningCancer risk predictionHealth dataCare physiciansGynecologic oncologistsRisk stratificationDisease onsetPositive rateIndividual patientsCancer riskInvasive proceduresScreening TrialPersonal health dataEarly cancer detectionMortality rateEarly screeningFalse positive ratePrevious risk models
2018
Imaging Dose, Cancer Risk and Cost Analysis in Image-guided Radiotherapy of Cancers
Zhou L, Bai S, Zhang Y, Ming X, Zhang Y, Deng J. Imaging Dose, Cancer Risk and Cost Analysis in Image-guided Radiotherapy of Cancers. Scientific Reports 2018, 8: 10076. PMID: 29973695, PMCID: PMC6031630, DOI: 10.1038/s41598-018-28431-9.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBone Marrow CellsBrainChildChild, PreschoolCone-Beam Computed TomographyCost-Benefit AnalysisFemaleHumansInfantLungMaleMiddle AgedMonte Carlo MethodNeoplasmsPhantoms, ImagingRadiation DosageRadiotherapy DosageRadiotherapy, Image-GuidedRisk FactorsThoraxYoung AdultConceptsCancer riskAssociated cancer riskImage-guided radiotherapyImaging proceduresLifetime attributable riskImaging dosesAverage lifetime attributable riskRadiological imaging proceduresRed bone marrowRetrospective studyCancer patientsLung cancerAttributable riskCancer incidenceBilling codesIndividual patientsBone marrowBrain cancerImage guidance proceduresPelvic scanPatientsCancerOrgan dosesRadiotherapyDoses
2016
Energy Modulated Photon Radiotherapy: A Monte Carlo Feasibility Study
Zhang Y, Feng Y, Ming X, Deng J. Energy Modulated Photon Radiotherapy: A Monte Carlo Feasibility Study. BioMed Research International 2016, 2016: 7319843. PMID: 26977413, PMCID: PMC4763028, DOI: 10.1155/2016/7319843.Peer-Reviewed Original ResearchConceptsIMRT plansPediatric brain tumorsNovel treatment modalitiesNormal tissue sparingDifferent tumor sitesDosimetric gainLung cancerTreatment modalitiesIndividual patientsBrain tumorsTissue sparingIMRT techniqueTumor sitePersonalized carePhoton radiotherapyThyroid lesionsDose distributionIntegral doseRadiotherapy treatmentInverse planning systemPatientsRadiotherapyFeasibility studyModern radiotherapy treatmentsClinical IMRT plans
2007
On the Need to Compensate for Edema-Induced Dose Reductions in Preplanned 131Cs Prostate Brachytherapy
Chen ZJ, Deng J, Roberts K, Nath R. On the Need to Compensate for Edema-Induced Dose Reductions in Preplanned 131Cs Prostate Brachytherapy. International Journal Of Radiation Oncology • Biology • Physics 2007, 70: 303-310. PMID: 17980500, PMCID: PMC2289996, DOI: 10.1016/j.ijrobp.2007.09.007.Peer-Reviewed Original ResearchConceptsDose reductionProstate brachytherapyDose compensationLarge edemaBiochemical recurrence-free survivalRecurrence-free survivalSignificant dose reductionEffects of edemaSublethal damage repairAdditional irradiationPrescription doseProstate cancerIndividual patientsEdemaEdema evolutionPrescribed doseProstate edemaEffective doseRadiobiologic effectsBrachytherapyDoseProstate implantsDose responseImplants